John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
A New Generation Comfortable Doing a Thousand Things at a Time Is Reinventing Life Science Says Joe Beechem of NanoString
Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.
The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae
The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script
Akoya Biosciences Launches New Integrated Spatial Platform: Our First Interview with CEO Brian McKelligon
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
Twist Bioscience: A New Kind of DNA Synthesis Company
Going High Resolution with 10X Genomics: Michael Schnall-Levin
George Church and Ben Lamm on the Launch of Colossal Biosciences
We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years
Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership
Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director
DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO
Tumor Evolution in Context with Christina Curtis
The History of mRNA Vaccines with Elie Dolgin
Hundreds of Thousands of Biological Molecules Undiscovered in Plant Chemical Space Says Founder of New Drug Discovery Company
Quantitative Pathology with David Rimm, Yale
The State of Comprehensive Genomic Profiling at One of America’s Largest Health Systems with Carlo Bifulco
Inside the World of Genome Engineering at Amyris with Kirsten Benjamin, VP of R&D
Create your
podcast in
minutes
It is Free
Sasquatch Chronicles
Radiolab
The Confessionals
Sasquatch Odyssey
Science Friday